Emergent BioSolutions (EBS) Current Deferred Tax Assets (2010 - 2015)
Emergent BioSolutions (EBS) posted quarterly Current Deferred Tax Assets of $1.5 million for Q3 2015, little changed quarter-over-quarter from $1.5 million in Q2 2015.
Emergent BioSolutions (EBS) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Emergent BioSolutions' Current Deferred Tax Assets history runs 6 years deep, the most recent figure standing at $1.5 million for Q3 2015.
- In Q3 2015, Current Deferred Tax Assets changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2015 stood at $1.5 million (changed N/A YoY), while the FY2014 annual figure was $1.7 million, changed N/A from the prior year.
- Current Deferred Tax Assets for Q3 2015 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $7.2 million in Q3 2011, with the low at $327000.0 in Q3 2012.
- The 5-year median for Current Deferred Tax Assets is $1.4 million (2012), against an average of $2.1 million.
- The sharpest annual moves came in 2012 and 2013: Current Deferred Tax Assets tumbled 95.46% in 2012, then soared 286.54% in 2013.
- Emergent BioSolutions' Current Deferred Tax Assets stood at $1.7 million in 2011, then decreased by 27.15% to $1.3 million in 2012, then changed by 0.0% to $1.3 million in 2013, then jumped by 35.28% to $1.7 million in 2014, then slipped by 13.27% to $1.5 million in 2015.
- Business Quant data shows EBS's Current Deferred Tax Assets at $1.5 million in Q3 2015, $1.5 million in Q2 2015, and $1.7 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 1.48 Mn |
| Sep 30, 2015 | 1.48 Mn |
| Jun 30, 2015 | 1.48 Mn |
| Jun 30, 2015 | 1.48 Mn |
| Mar 31, 2015 | 1.66 Mn |
| Mar 31, 2015 | 1.66 Mn |
| Dec 31, 2014 | 1.71 Mn |
| Dec 31, 2014 | 1.71 Mn |
| Sep 30, 2013 | 1.26 Mn |
| Sep 30, 2013 | 1.26 Mn |
| Jun 30, 2013 | 1.26 Mn |
| Jun 30, 2013 | 1.26 Mn |
| Mar 31, 2013 | 1.26 Mn |
| Mar 31, 2013 | 1.26 Mn |
| Dec 31, 2012 | 1.26 Mn |
| Dec 31, 2012 | 1.26 Mn |
| Sep 30, 2012 | 327,000.00 |
| Sep 30, 2012 | 327,000.00 |
| Jun 30, 2012 | 638,000.00 |
| Jun 30, 2012 | 638,000.00 |